Product Safety Recalls

Product Recall Tracker

Recall D-0747-2022

Description: NETSPOT (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, kit contains Vial 1 (Reaction vial with lyophilized powder), 1 Single dose vial, consisting of 40 mcg of dotate, 5 mcg of 1,10-phenanthroline, 6 mcg of Gentisic acid, 20 mg of D-Mannitol, and Nitrogen; and Vial 2, 1 Single dose vial of reaction buffer, Rx Only, Manufactured for: Advanced Accelerator Applications USA, Inc., by: Gipharma S.r.l., Strada Crescentino snc, 13040 Saluggia (Vc), Italy, NDC 69488-001-40

Recall D-0747-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0747-2022
Event ID89885
BrandNETSPOT
Generic Name68GA-DOTATATE
Manufacturer68GA-DOTATATE
Original Package?1
Drug RouteINTRAVENOUS
DistributionNationwide in the USA and Puerto Rico
Quantity14,089 kits
Recall ReasonSubpotent Drug: low out-of-specification results for Vial 1 assay obtained during stability studies.
Drug ClassificationClass III
Drug Code Info20220413
Product NDC69488-001
Recall Initiation Date20220318
Report Date20220413
Classification Date20220406
Address57 E Willow St
Millburn, NJ 07041-1416
United States
Recalling FirmAdvanced Accelerator Applications USA, Inc.
Initial Notification Letter
Drug Application NumberNDA208547
Structured Product Labeling (SPL ID)e9d3e09e-a97f-4b81-9b6c-83598e3f1e32
Structured Product Labeling (SPL Set ID)b2b3be70-17d8-4093-896c-f1c54a2cf242
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.